Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery-Reference-Cited by-同舟云学术

Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery

Published:2019-09 Issue:5 Volume:2 Page:589-596
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Van den Broeck Thomas,Moris Lisa,Gevaert Thomas,Tosco Lorenzo,Smeets Elien,Fishbane Nick,Liu Yang,Helsen Christine,Margrave Jennifer,Buerki Christine,Davicioni Elai,Van Poppel Hendrik,Everaerts Wouter,Weinmann Sheila,Den Robert,Davis John,Schaeffer Edward,Karnes R. Jeffrey,Claessens Frank,Joniau Steven

Funder

Research Foundation Flanders

KU Leuven

FWO-Vlaanderen

Kom op tegen Kanker

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference28 articles.

1. Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy;Yossepowitch;Eur Urol,2008

2. Androgen deprivation therapy: evidence-based management of side effects;Ahmadi;BJU Int,2013